Research
Associations of anti-carbamylated protein antibodies with systemic inflammation and osteoporosis in rheumatoid arthritis: a cross-sectional study
Nature ·
The Brief
- A cross-sectional study examined anti-carbamylated protein (anti-CarP) antibodies in rheumatoid arthritis patients.
- The study reports associations of these antibodies with systemic inflammation.
- The study also reports associations of these antibodies with osteoporosis.
Why it matters
Linking anti-CarP antibodies to inflammation and osteoporosis in rheumatoid arthritis could help clinicians and researchers understand bone involvement in the disease. As a cross-sectional study, it shows associations rather than cause and effect.
Who’s affected
- rheumatologists and clinicians treating rheumatoid arthritis
- researchers studying autoantibodies, inflammation and bone health
- #rheumatoid arthritis
- #osteoporosis
- #autoantibodies
- #systemic inflammation
- #carbamylation